TRANSCODE THERAPEUTICS INC
(NASDAQ: RNAZ)
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
0.461
+0.002
(+0.44%)
Range
- - -
(-%)
Open
-
Previous Close
0.459
Bid Price
5.860
Bid Volume
10
Ask Price
6.410
Ask Volume
10
Volume
66,040
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis